Octreotide Acetate Salt API CAS 79517-01-4 | Peptide Manufacturer
Octreotide Acetate Salt API CAS 79517-01-4 | Peptide Manufacturer
Octreotide Acetate API,CAS 79517-01-4,Octreotide Acetate,Custom Peptide Synthesis,Bulk Peptide Supplier,somatostatin analog,SSTR2 SSTR5 agonist,cGMP Peptide Manufacturing
Source high-purity Octreotide Acetate peptide API (CAS 79517-01-4) directly from cGMP manufacturer. Purity ≥98.0% by HPLC. Flexible packaging from mg to bulk kg for acromegaly formulation R&D.
Send Inquiry
Description
cGMP STANDARD PHARMACEUTICAL PEPTIDE SUPPLIER
Octreotide Acetate Salt
CAS No.: 79517-01-4
Purity (HPLC)≥ 98.0%
Molecular FormulaC49H66N10O10S2 · xCH3COOH
Molecular Weight1079.3 Da (Acetate Salt)
Peptide Content / AcetateCustom / Controlled
💡 Quick Connection Notice: If your email link doesn't open, please directly send inquiries to: betty@pharma-sunrise.com
Scientific Overview & High-Quality Custom Peptide Synthesis
We specialize in the supply of high-purity Octreotide Acetate API, a synthetic somatostatin octapeptide analog. All batches undergo strict HPLC quality testing and comprehensive in-house quality control procedures under cGMP guidelines to ensure exceptional batch-to-batch consistency. By effectively mimicking the physiological functions of natural somatostatin while offering higher biological potency and a significantly longer in vivo half-life, this product is highly valued in the global biopharmaceutical industry.
Our products fully meet international pharmaceutical specifications. Dedicated to providing premium synthetic peptide APIs alongside professional technical support, we reliably support your entire process pipeline—from laboratory formulation research, pre-clinical trials to large-scale commercial manufacturing across endocrinology, oncology, and gastroenterology fields, serving as your trustworthy long-term strategic raw material supplier.
Pharmacological Profile & API Formulation Targets
Mechanism of Action (MoA)
Octreotide exerts targeted regulatory effects by binding selectively with high affinity to somatostatin receptor subtypes SSTR2 and SSTR5. Upon binding, it inhibits downstream intracellular signal transduction pathways, effectively blocking the synthesis and release of targeted hormones and dampening abnormal hyper-secretion to achieve systemic hormonal balance.
Clinical Formulation Goals
Downstream finished preparations aim to strongly inhibit the excessive secretion of growth hormone, glucagon, insulin, gastrin, and vasoactive intestinal peptide (VIP). Clinically, this API is targeted for commercial formulations addressing acromegaly, neuroendocrine tumor complications (such as carcinoid syndrome and VIPoma), and the regulation of visceral hemodynamics (e.g., reducing portal venous pressure).
Pharmaceutical Applications & Extended Research
Commercial Manufacturing: Core active raw material for injectables managing cirrhotic variceal bleeding and endocrine disorders.
Clinical & R&D Exploration: Extensively utilized in adjuvant therapy research for tumor chemotherapy complications, pancreatic surgical protection drug development, and foundational studies concerning somatostatin receptor signaling mechanisms.
Technical Specifications & Cold Chain Logistics Standard
| Product Identity | Octreotide Acetate (Synthetic Polypeptide API) |
|---|---|
| Physical Characteristics | White to off-white lyophilized powder |
| Testing Method & Purity | High Performance Liquid Chromatography (HPLC); ≥ 98.0% |
| Flexible Packaging Options | • R&D Scale: 10–100 mg per sterile glass vial • Pilot/Commercial Scale: 1–5 kg per advanced aluminum vacuum foil bag • Bulk Export: 25 kg per robust industrial fiber drum *Customized packaging configurations are fully supported upon request. |
| Storage & Cold Chain Mandates | Store in a tightly sealed container at frozen conditions -20°C ± 5°C. Protect diligently from light and moisture ingress, and avoid repeated freeze-thaw cycles to preserve structural integrity. |
| Shelf Life Reference | 36 months under the proper recommended sealed and low-temperature storage conditions. |
Frequently Asked Questions (Peptide Procurement)
Can you guarantee the peptide sequence accuracy and provide batch testing data?
Yes. Our Octreotide Acetate API undergoes rigorous quality control and solid-phase synthesis monitoring. We provide a complete Certificate of Analysis (COA) with every batch, backed by comprehensive HPLC chromatograms ensuring ≥98.0% purity, alongside Mass Spectrometry (MS) data to verify absolute structural identity and batch consistency.
Do you accommodate custom packaging sizes for laboratory scale R&D?
Absolutely. We fully support custom peptide synthesis pipelines. Beyond our commercial 1kg to 5kg foil bags, we provide highly precise mg-scale sterile vials (10mg - 100mg) specifically designed to facilitate early-stage pre-clinical trials and new drug formulation development without material waste.
How is the -20°C storage requirement managed during international shipping?
To ensure the complete molecular integrity of the lyophilized peptide powder, we deploy specialized cold-chain logistics for all international shipments. The API is securely vacuum-sealed in moisture-proof aluminum foil and shipped utilizing validated temperature-controlled containers equipped with integrated temperature data loggers.
Is this API available for direct clinical injection or patient use?
No. As clearly stated in our declaration, this product is an active pharmaceutical ingredient (API) and research chemical. It is strictly intended for laboratory scientific research and B2B finished drug manufacturing under professional oversight only. It cannot be used directly for human clinical medication or commercial food/cosmetic purposes.
Shaanxi Sunrise Pharmaceutical Co., Ltd.
Senior Independent Site Operations Specialist: Betty
📧 Email: betty@pharma-sunrise.com|💬 WhatsApp: +86 18092760627